JESSICA CONANT: Open Payments
NPI 1821650763 · RICHMOND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,154 in 118 payments from 23 companies in 2025. Trend: 2023 $1,957 · 2024 $1,768 · 2025 $2,154
Food & beverage: $2,154
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $352 |
| ABBVIE INC. | 23 | $263 |
| AstraZeneca Pharmaceuticals LP | 11 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $193 |
| Vanda Pharmaceuticals Inc. | 8 | $160 |
| Teva Pharmaceuticals USA, Inc. | 10 | $158 |
| Dexcom, Inc. | 6 | $146 |
| Amgen Inc. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Viatris Specialty LLC | 4 | $78 |
Products named: FREESTYLE LIBRE 3, VRAYLAR, CAPLYTA, AUSTEDO XR, Dexcom G6 Transmitter, AIRSUPRA, FANAPT, REXULTI.
Industry payments across MO — which companies pay providers there.
